Advertisement

Topics

Life Science Big News Roundup: Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc.; Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell; Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Mi

13:00 EDT 17 May 2019 | Investing News Network

In case you missed it, here is this week’s life science big news roundup.

The post Life Science Big News Roundup: Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc.; Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell; Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations appeared first on Investing News Network.

Original Article: Life Science Big News Roundup: Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc.; Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell; Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Mi

NEXT ARTICLE

More From BioPortfolio on "Life Science Big News Roundup: Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc.; Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell; Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Mi"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...